S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

RYTM Rhythm Pharmaceuticals Inc

40.98

-0.45 (-1.09%)

03 May 2024 - Closed

Delayed by 15 minutes

Dosing underway in Rhythm Pharma's setmelanotide trial for rare genetic disease of obesity

To read the full story on Seeking Alpha, click here.

Rhythm Pharmaceuticals (NASDAQ:RYTM)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Rhythm Pharmaceuticals Charts.

Rhythm Pharmaceuticals (NASDAQ:RYTM)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Rhythm Pharmaceuticals Charts.

Rhythm Pharmaceuticals Inc News

Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & Endocrinology
Tuesday 30 April 2024 (3 days ago) • GlobeNewswire Inc.

Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
Thursday 25 April 2024 (1 week ago) • GlobeNewswire Inc.

Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Wednesday 17 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock Financing
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.

Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific Agonist
Monday 25 March 2024 (1 month ago) • GlobeNewswire Inc.

Rhythm Pharmaceuticals Announces New Employment Inducement Grants
Tuesday 12 March 2024 (2 months ago) • GlobeNewswire Inc.

Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conferences
Thursday 7 March 2024 (2 months ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

More Rhythm Pharmaceuticals Inc News Articles

Newcrest Mining

Australian SE All Ordina...

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions